Loading people...
Ananya Zutshi is the Co-Founder and Chief Executive Officer of Guardian Bio, a biotechnology startup developing dendritic cell-based immunotherapies. She holds a Bachelor of Science in Engineering from Duke University, alongside a Master of Engineering and a Master of Business Administration from Harvard University. Prior to establishing Guardian Bio, Zutshi built a multidisciplinary career spanning pharmaceutical operations, engineering, project management, and early-stage venture capital investing within the life sciences industry. She leverages her dual background in scientific training and business administration to advance novel healthcare innovations, translating complex immunological research into viable therapeutic treatments. Beyond her executive leadership duties, she actively advocates for diversity, equity, and inclusion initiatives across the biotechnology ecosystem. Zutshi currently focuses on scaling Guardian Bio to successfully modulate patient immune responses through specialized cell therapies, driving the next generation of targeted immunology treatments.
Ananya Zutshi is Corporate Development at Caldera Therapeutics, based in Boston, MA, USA.
Ananya Zutshi has founded companies and has also been involved with Guardian Bio, Harvard Business School, Cellino, Petri, Catalent, Duke University, All India Institute of Medical Sciences.
